
The routine use of potent anti-coagulants following TJR is unnecessary

The routine use of potent anti-coagulants following TJR is unnecessary
Meta-analysis of cause of death following total joint replacement using different thromboprophylaxis regimens
J Bone Joint Surg Br. 2012 Jan;94(1):113-21Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
The findings of 70 publications, focusing on total joint replacement (TJR) which used some form of thromboprophylaxis, were combined to assess the effect of throboprophylaxis on mortality and proportion of deaths due to a known or suspected pulmonary embolism (PE) in modern TJR. 99441 patients were categorized into 7 groups based on the type of throboprophylaxis. Death occurred in 373 of the patie...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!

Learn about our AI Driven
High Impact Search Feature

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.